| Browse All

Polyrizon Ltd. (PLRZ)

Healthcare | Biotechnology | Ra'anana, Israel | NasdaqCM
11.41 USD +0.47 (4.296%) ⇧ (April 17, 2026, 4 p.m. EDT)
After hours: 11.25 -0.16 (-0.160%) ⇩ (April 17, 2026, 7 p.m. EDT)

Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 11, 2026, 4:13 p.m. EDT

Polyrizon Ltd. (PLRZ) presents a highly volatile and risky investment opportunity. The stock has experienced significant price fluctuations over the past 14 days, with a recent close of $10.83, which is below the 50-day moving average of $13.266. The stock's price has been trending downward, indicating a lack of momentum and potential bearish sentiment. The company's fundamentals are weak, with negative earnings and return on equity, suggesting poor financial health. Additionally, the company has no dividend history, making it unsuitable for dividend-focused investors. Given the recent news of fundraising activities and the lack of positive momentum, it is advisable to avoid short-term trading and long-term holding of this stock.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.092227
MSTL0.095876
AutoETS0.097389
AutoTheta0.291440

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 49%
H-stat 4.23
Ljung-Box p 0.000
Jarque-Bera p 0.537
Excess Kurtosis 0.11
Attribute Value
Sector Healthcare
Market Cap 20,342,068
Website https://www.polyrizon-biotech.com

Info Dump

Attribute Value
52 Week Change -0.977899
Address1 5 Ha-Tidhar Street
All Time High 7,200.0
All Time Low 2.88
Ask 14.28
Ask Size 2
Average Daily Volume10 Day 45,350
Average Daily Volume3 Month 51,198
Average Volume 51,198
Average Volume10Days 45,350
Bid 8.43
Bid Size 2
Book Value 13.054
City Ra'anana
Compensation As Of Epoch Date 1,767,139,200
Country Israel
Crypto Tradeable 0
Currency USD
Current Price 11.41
Current Ratio 29.029
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 11.875
Day Low 11.0
Display Name Polyrizon
Ebitda -5,907,000
Ebitda Margins 0.0
Enterprise To Ebitda -1.056
Enterprise Value 6,235,880
Eps Trailing Twelve Months -4.9
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 12.99596
Fifty Day Average Change -1.5859604
Fifty Day Average Change Percent -0.12203488
Fifty Two Week Change Percent -97.7899
Fifty Two Week High 2,235.0
Fifty Two Week High Change -2,223.59
Fifty Two Week High Change Percent -0.9948949
Fifty Two Week Low 2.88
Fifty Two Week Low Change 8.53
Fifty Two Week Low Change Percent 2.9618053
Fifty Two Week Range 2.88 - 2235.0
Financial Currency USD
First Trade Date Milliseconds 1,730,208,600,000
Float Shares 1,529,635
Free Cashflow -2,566,625
Full Exchange Name NasdaqCM
Full Time Employees 2
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.00964
Held Percent Institutions 0.02224
Implied Shares Outstanding 1,782,828
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ipo Expected Date 2,024-10-29
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,764,288,000
Last Split Factor 1:6
Long Business Summary Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Long Name Polyrizon Ltd.
Market us_market
Market Cap 20,342,068
Market State CLOSED
Max Age 86,400
Message Board Id finmb_72428529
Most Recent Quarter 1,767,139,200
Net Income To Common -3,335,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 20,342,067
Open 11.3394
Operating Cashflow -4,528,000
Operating Margins 0.0
Payout Ratio 0.0
Phone 972 9 374 0120
Post Market Change -0.15989971
Post Market Change Percent -1.4013997
Post Market Price 11.2501
Post Market Time 1,776,466,838
Previous Close 10.94
Price Hint 2
Price To Book 0.8740616
Profit Margins 0.0
Quick Ratio 27.704
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.47
Regular Market Change Percent 4.29616
Regular Market Day High 11.875
Regular Market Day Low 11.0
Regular Market Day Range 11.0 - 11.875
Regular Market Open 11.3394
Regular Market Previous Close 10.94
Regular Market Price 11.41
Regular Market Time 1,776,456,000
Regular Market Volume 62,873
Return On Assets -0.28948
Return On Equity -0.25381002
Sand P52 Week Change 0.36506534
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 1,782,828
Shares Percent Shares Out 0.021300001
Shares Short 34,582
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 42,068
Short Name Polyrizon Ltd.
Short Percent Of Float 0.0217
Short Ratio 1.21
Source Interval 15
Symbol PLRZ
Total Cash 12,273,000
Total Cash Per Share 7.566
Total Debt 0
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -4.9
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 9.113125
Two Hundred Day Average Change 2.296875
Two Hundred Day Average Change Percent 0.25204033
Type Disp Equity
Volume 62,873
Website https://www.polyrizon-biotech.com
Zip 4,366,507